Oramed Pharmaceuticals Inc starts Phase 3 Trial of Oral Insulin
Oramed Pharmaceuticals Inc announced that it has screened the first patients in its global Phase 3 trials of its oral insulin capsule ORMD-0801 for...
BAT moves Covid candidate vaccine towards Phase I human clinical trials
BAT has announced plans to commence a Phase I first-time-in-human study of its Covid-19 vaccine candidate.
The announcement by BAT's US Bio-tech arm, Kentucky BioProcessing...
Aster Labs unveils Digital Pathology Solution approved by USFDA
Aster Labs has introduced US FDA approved digital pathology solution at two of its facilities.
The diagnostics arm of Aster DM Healthcare, a healthcare service...
LumiraDx gets approval for its COVID-19 Antigen Test in India
Diagnostics testing company LumiraDx has received emergency use approval by India's Central Drugs Standard Control Organisation for its SARS-CoV-2 Antigen test for use in...
Happy news on war against Covid-19, Sputnik V vaccine to hit market in affordable...
Russia's sovereign wealth fund, Russian Direct Investment Fund (RDIF) has announced the cost of the Sputnik V vaccine for international markets will be less...
Research on preventative nasal spray reveals interesting results
Research on a 'novel' nasal spray therapy, INNA-051, which has been shown to reduce Covid-19 viral replication by up to 96 percent in a...
Kinetic unveils UVC light-based sanitiser that kills 99.9% of coronavirus in 15 minutes
Kinetic Communications Ltd; a member of the Kinetic Group, has introduced 'UV WARRIOR', a portable disinfector that 'sanitises all daily objects and any room...
Freudenberg Medical showcases its silicone tubing, assemblies at CPhi & PMEC India 2021
Freudenberg Medical, a global contract manufacturer of medical device components and biopharma tubing, has showcased its premium silicone tubing, hose, and assemblies at India’s...
Bausch starts study for dry eye disease linked with Meibomian Gland Dysfunction
Bausch Health Companies Inc and its global eye health business Bausch + Lomb have announced that the second of two Phase 3 studies evaluating...
NIH & BARDA react to emergency use authorisation of Moderna Covid-19 vaccine by FDA
NIH and BARDA have reacted to the United States Food and Drug Administration's Emergency Use Authorization (EUA) to Moderna, Inc., a biotechnology company based...
